foxo4-dri senolytic 2024 study Frontiers FOXO4-DRI: The Senolytic Peptide That

Peptides that address gut inflammation and barrier integrity, particularly BPC-157 and KPV, may prove relevant to MS management in ways that were inconceivable a decade ago

app.patientaccess.com The easiest way to sign up is to ask your GP surgery for an introduction letter (can't remember what they call it I'm afraid,) they'll give you a letter with links & a sign in code

The information below is for educational purposes only

Unlike corticosteroid injections (which reduce pain short-term but damage cartilage long-term), BPC-157 appears to be cartilage-sparing and potentially cartilage-supportive making it relevant for early-stage osteoarthritis or post-injury joint degradation

Inflammation, stiffness, or reduced mobility